Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug2437 | Motivational social support from nurse with additional support from significant other Wiki | 1.00 |
| drug2436 | Motivational social support from nurse Wiki | 1.00 |
| drug2501 | Nasal Dexamethasone Wiki | 1.00 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D007511 | Ischemia NIH | 0.35 |
| D003324 | Coronary Artery Disease NIH | 0.33 |
| D006331 | Heart Diseases NIH | 0.27 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| HP:0001677 | Coronary artery atherosclerosis HPO | 0.33 |
| HP:0001658 | Myocardial infarction HPO | 0.22 |
Navigate: Correlations HPO
There is one clinical trial.
This Clinical Trial evaluates nasal administration of Dexamethasone as an adjuvant treatment strategy for non-critically ill hospitalized participants with SARS CoV-2 infection.
Description: Evaluation of the clinical status of patients after randomization, defined as a two point improvement in the WHO 7-point Ordinal Scale
Measure: Time of clinical improvement Time: 10 days after randomizationDescription: All-cause mortality rates at 28 days after randomization
Measure: Time-to-death from all causes Time: 28 days after randomizationDescription: Ventilator-free days, defined as alive and not requiring mechanical ventilation, at 10 days after randomization.
Measure: Time free from mechanical ventilation Time: 10 days after randomizationDescription: Virological measurements, including proportions with detection of viral RNA over time and measurements of viral RNA titer area under the curve (AUC).
Measure: Viral load Time: 10 days after randomizationDescription: Length of hospital stay in days
Measure: Length of hospital stay Time: 10 days after randomizationAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports